{"version":"1.0","provider_name":"Avalere Health Advisory","provider_url":"https:\/\/advisory.avalerehealth.com","title":"Impacts of 340B on State Medicaid Programs and Patient OOP Costs | Avalere Health Advisory","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"ewUvpQi51a\"><a href=\"https:\/\/advisory.avalerehealth.com\/insights\/impacts-of-340b-on-state-medicaid-programs-and-patient-oop-costs\">Impacts of 340B on State Medicaid Programs and Patient OOP Costs<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/advisory.avalerehealth.com\/insights\/impacts-of-340b-on-state-medicaid-programs-and-patient-oop-costs\/embed#?secret=ewUvpQi51a\" width=\"600\" height=\"338\" title=\"&#8220;Impacts of 340B on State Medicaid Programs and Patient OOP Costs&#8221; &#8212; Avalere Health Advisory\" data-secret=\"ewUvpQi51a\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n<\/script>\n","thumbnail_url":"https:\/\/advisory.avalerehealth.com\/wp-content\/uploads\/2024\/08\/32917-1-EmilyDonaldson-400x600-1.jpg","thumbnail_width":600,"thumbnail_height":400,"description":"Persistent growth in the 340B Drug Pricing Program is raising questions about the financial impact to patients, other stakeholders, and the healthcare system overall. To address some of these questions, Avalere analyzed how state Medicaid programs are impacted by foregone rebates when 340B covered entities carve claims out of the Medicaid program and into 340B&hellip;"}